Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Share Us

Novel Antibody Therapeutics Congress

View: 421

Website | Edit Freely

Category Oncology; antibodies; immuno-oncology; biotherapeutics

Deadline: October 04, 2019 | Date: October 10, 2019-October 11, 2019

Venue/Country: London Heathrow Marriott Hotel, U.K.

Updated: 2018-12-04 21:35:59 (GMT+9)

Call For Papers - CFP

Designed for experts in pharma and academia, this conference will explore the latest advances in antibody-based therapeutics in oncology. Talks will review the recent developments in bispecific antibody technology, as well as exploring the potential of new antibody and antibody-mimicking formats. A dedicated checkpoint blockades session will also examine new approaches in neutralizing cancer cell immune blockades, including advances in PD1, PD-L1 and CTLA4 targeting therapeutics, and the discovery and targeting of new biomarkers

With recent breakthroughs in immunotherapeutics, biotherapeutics are set to lead the way in oncology in the coming years. As one of the dominant biologic formats, monoclonal antibodies stand ready to capitalise on this, building on two decades offered of exciting advancements in the treatment of cancer.

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.